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The Deciphering the Mechanisms of Developmental Disorders programme has analysed the
morphological and molecular phenotypes of embryonic and perinatal lethal mouse mutant
lines in order to investigate the causes of embryonic lethality. Here we show that individual
whole-embryo RNA-seq of 73 mouse mutant lines (>1000 transcriptomes) identiﬁes tran-
scriptional events underlying embryonic lethality and associates previously uncharacterised
genes with speciﬁc pathways and tissues. For example, our data suggest that Hmgxb3 is
involved in DNA-damage repair and cell-cycle regulation. Further, we separate embryonic
delay signatures from mutant line-speciﬁc transcriptional changes by developing a baseline
mRNA expression catalogue of wild-type mice during early embryogenesis (4–36 somites).
Analysis of transcription outside coding sequence identiﬁes deregulation of repetitive ele-
ments inMorc2a mutants and a gene involved in gene-speciﬁc splicing. Collectively, this work
provides a large scale resource to further our understanding of early embryonic develop-
mental disorders.
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Animal models are a powerful surrogate for the study ofhuman development and disease. Genetic screens haveproduced large mutation resources in the model organ-
isms Caenorhabditis elegans1–3, Drosophila melanogaster4,5 and
Danio rerio6. The creation of a collection of mutants covering
every gene of the mammalian model Mus Musculus is currently
underway, coordinated by the International Mouse Phenotyping
Consortium7 (IMPC). Adult knock-out mice undergo a range of
systematic phenotypic assessments to deﬁne genotype−pheno-
type associations. These data provide vital information to further
our understanding of human disease and developmental
disorders8.
It is estimated that around a third of all knock-out mutations in
mice result in embryonic or perinatal (EP) lethality9 and in these
lines the adult phenotype can only be assessed in heterozygous
individuals. Lethal lines, however, provide an opportunity to
study embryonic anomalies and their correlates with human
congenital disorders. The Deciphering the Mechanisms of
Developmental Disorders (DMDD) programme was a 5-year
project to systematically characterise EP lethal IMPC lines
(deﬁned as the absence of homozygous mutants after screening a
minimum of 28 pups at P14).
The project has analysed over 240 mutant lines over the past 5
years and has created a public resource including embryonic
high-resolution episcopic microscopy10 (HREM) and placenta
morphology assessment11. In this work, we present the tran-
scriptomic analysis of a subset of these lines.
The DMDD programme assessed morphological phenotypes in
E14.5 embryos, a time point when organogenesis is largely
complete12, and identiﬁed highly variable penetrance of mor-
phological phenotypes13,14. Careful staging showed that the
majority of homozygous embryos were delayed at E14.5 15.
Around 170 of the DMDD mutant lines (70%) did not produce
viable homozygous embryos at E14.5 and therefore subsequent
litters were analysed at mid-gestation (E9.5). In a third of these
lines homozygous embryos could be retrieved at E9.5 with a
subset displaying mild to severe developmental delay16. In addi-
tion to the embryos, placental tissues and yolk sacs were analysed
which showed a high percentage of placental phenotypes among
the embryonic-lethal mutant lines17.
In this current work, we analysed transcriptome proﬁles of 73
embryonic-lethal mutant lines using individual whole embryos at
E9.5. The embryos were staged using somite number to provide a
more ﬁne-grained and accurate developmental assessment than
embryonic days post conception. Somite number connects stage
to actual developmental progression independent from time post
conception. Accurate staging is crucial to untangling the direct
effects of the mutation on gene expression levels from gene
expression changes due to mutant embryos being devel-
opmentally younger. However, because only the mutant embryos
are delayed, it is difﬁcult to separate these signals. We have
therefore created a baseline of wild-type transcriptomes over the
period of somite formation as a stage reference. Using this
baseline we have developed a method to enrich for the direct
effects of the mutation on gene expression and identify a separate
signature caused by developmental delay. We have also produced
a Shiny app called Baseline CompaRe (https://www.sanger.ac.uk/
science/tools/dmdd/dmdd/) to enable researchers to visualise the
data presented here and to apply the method of delay signal
separation on other suitable datasets.
To perform these studies we use whole-organism RNA-seq
since we and others have shown that this is a powerful method to
deﬁne transcriptomic landscapes and identify genetic interac-
tions18–20. Using this approach, we identiﬁed the molecular
phenotypes of 53 homozygous mutant lines as well as of 20 lines
where only heterozygous embryos could be retrieved at E9.5. We
aimed to identify gene regulatory signatures underlying devel-
opmental delay and associate previously uncharacterised genes
with speciﬁc pathways and developmental processes.
Results
The reference transcriptome of early mouse embryogenesis. To
produce a comprehensive baseline dataset of normal mRNA
expression around E9.5, we collected somite-staged wild-type
embryos from 4 to 28 somites (covering E8–E9.5) and 34 to
36 somites (E10.5 for comparison) with 3–4 embryos per
somite number (Fig. 1a). In total, we produced RNA-seq
libraries from polyA+ mRNA for 111 individual embryos,
which were sequenced at a mean read depth of 33.8 M mapped
reads per sample (Supplementary Data 1). After mapping, we
performed Markov clustering (MCL) on the data using the
BioLayout Express3D software21,22. Clustering the samples using
Pearson correlation produced three unconnected clusters,
suggesting a batch effect (Supplementary Fig. 1a). Clustering
the genes by correlation of expression levels to produce a gene
expression network (Fig. 1b) conﬁrmed that this was caused by
a set of genes that had high expression for the 17–20 somite
samples, which were all processed together (Fig. 1b, cluster
labelled Batch outliers), while all other samples showed low
expression. A large number of the genes in this cluster (41/194)
were histone cluster genes, which are not polyadenylated23 and
so should not be present in poly-A pulldown RNA-seq. For
these reasons, we believe this to be a technical artefact. Once
these 194 genes (Supplementary Data 2) were removed, all of
the samples clustered together in the sample correlation net-
work (Supplementary Fig. 1a–b), showing that no large batch
effects remain. We also removed Y chromosome genes and Xist
(Fig. 1b), so that an imbalance in the sexes of sampled mutant
and sibling embryos did not cause sex-speciﬁc genes to appear
to be differentially expressed. Finally, genes encoded by the
mitochondrial genome were removed as they are highly variable
(Fig. 1b, MT genes) and so are prone to appearing differentially
expressed by chance.
The clustered gene expression network also identiﬁed sets of
genes with speciﬁc trajectories over the investigated timescale.
The cluster labelled “Highly variable and decreasing” (Fig. 1b)
contains genes whose expression is variable early on in the time
course. The large range of expression levels at early time points
means homozygous embryos could appear signiﬁcantly different
from siblings by chance at these stages. Other notable clusters
included genes whose expression increases, decreases or is
relatively stable (Fig. 1b, clusters labelled Increasing, Decreasing
and Stable).
To investigate our ability to detect transcripts in whole
embryos we compared our data with previously generated
single-tissue RNA-seq24 (six tissues dissected from E8.25
embryos). Of the protein-coding genes detectable with either
whole-embryo or single-tissue RNA-seq (≥10 counts in any stage
or tissue), the majority were found by both techniques (94.9%,
14,118 of 14,871; Supplementary Fig. 1c) and just a small subset
were detected either in whole embryo only (2.1%, 306) or in
single tissue alone (3.0%, 447; Supplementary Fig. 1d). In our
transcriptome analysis of all embryonic samples we found a total
of 346 previously unannotated mouse genes, of which 16 are
protein coding and 330 are noncoding (Fig. 1c and Supplemen-
tary Data 3). These genes showed varied and dynamic expression
patterns throughout our baseline (Fig. 1d). The baseline data have
been incorporated in the Ensembl genome browser (https://www.
ensembl.org/Mus_musculus/Info/Index) as RNA tracks which
can be viewed by turning them on using the Control Panel (under
the heading RNASeq models).
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Fig. 1 Experimental strategy and data processing. a Experimental workﬂow for E9.5 baseline and mutant line analysis. For the baseline, wild-type mice from
heterozygous incrosses generated as part of the DMDD project were outcrossed (WT strain cross) and embryos from these crosses were collected. This
was to produce embryos with a similar genetic background to the mutants. For the mutant lines, embryos were obtained from heterozygous intercrosses
(Het mutant cross). The processed data can be viewed using Baseline CompaRe. The baseline data are available in Expression Atlas. b Clustered gene
expression network identiﬁes co-expressed genes across the baseline samples. The gene expression data are displayed using BioLayout Express3D as a
network of genes (nodes) with edges connecting nodes whose expression values over all the samples have a Pearson correlation coefﬁcient of ≥0.85.
Nodes represent 9265 genes and are coloured according to Markov clustering (MCL). Surrounding graphs show expression of genes in a selection of
clusters with individual embryos ordered by somite number on the x-axis, and gene expression in the cluster (unit variance scaled with standard deviation)
on the y-axis. Batch outliers (top left) are genes that were blacklisted from further analysis. Decreasing/increasing genes are the ones most indicative of
stage as they change the most across the time course, whereas the cluster labelled Stable is more consistent. Highly variable and decreasing is a set of
genes that have high variance even among embryos at the same stage. Single embryo signal is a cluster of genes that are expressed at high levels in just
one embryo. Xist, Y chr genes and MT genes (genes encoded by the mitochondrial chromosome) were removed due to high variability. c Venn diagram of
the categories of novel (previously unannotated) genes identiﬁed using all RNA-seq data across all embryos. d Heatmap of expression proﬁles of the novel
genes. Each row is a gene and each column a sample in somite number order. In each row, expression data are scaled to the maximum value (set to 1) for
that row. The genes are ordered by hierarchical clustering. Source data are provided as a Source Data ﬁle
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Dissection of transcriptional proﬁles of 73 mutant lines. We
collected embryos at E9.5 from heterozygous incrosses of
homozygous lethal lines (Fig. 1a, Het mutant cross). Each embryo
was staged according to somite number, genotyped, and pro-
cessed for mRNA extraction (Supplementary Data 4). Genotyping
showed that we obtained between 2 and 16 homozygous indivi-
duals for 53 lines, whereas for the remaining 20 lines only het-
erozygous and wild-type embryos could be recovered at this
developmental stage. Embryonic lethality is often preceded by
general developmental delay, which we observed in 31.6% of
homozygous embryos (79 of 250; Supplementary Data 4). In these
cases, we reasoned that the transcriptional response due to the
mutation would be confounded with a secondary, more generic,
delay signature that could be visualised by principal component
analysis (PCA). Principal component (PC) 3 (by deﬁnition the
third strongest signal in the data, accounting for 6.3% of all the
variance) correlates very well (Pearson correlation coefﬁcient=
−0.865) with the recorded somite number (Fig. 2a). The genes
that contribute most to this PC are the ones that change the most
(either increasing or decreasing) across the time course and are
therefore indicative of stage (Fig. 1b, clusters labelled Increasing
and Decreasing; see gene list in Supplementary Data 5). These
included well-known developmental transcription factors such as
NeuroD1, Cdx2 and Myog, suggesting that PC3 represents a
common developmental stage signal likely to affect the differ-
ential expression analysis.
Accounting for developmental delay. We therefore devised a
strategy to separate the transcriptional signal due to delay from
the primary transcriptional response to gene disruption. Because
embryos at E9.5 have 21–29 somites25, we deﬁned a mutant as
developmentally delayed if at least one of the embryos had fewer
than 20 somites, allowing for a one-somite counting error. We
subjected transcriptional proﬁles for mutant lines deﬁned in this
way to differential gene expression (DGE) analysis in three ways
(Fig. 2b, Supplementary Fig. 2). First, we identiﬁed DGE by
running homozygous samples against their siblings (Supple-
mentary Fig. 2a, median 4 vs. 9 embryos). Second, we included
baseline samples for the stages present in the experimental
embryos to better estimate normal variance for each gene (Sup-
plementary Fig. 2b). For example, in the Brd2 mutant line, the
experimental samples are from 13, 15, 19–20, 22 and
25–28 somite stages so baseline samples from the same stages
were included (Supplementary Fig. 2b, grey shading). Third, in
addition to including the baseline as above, we deﬁned the
number of somites as a group in the DESeq2 model to take
developmental stage for each embryo into account (Supplemen-
tary Fig. 2c). Overlapping the resulting DGE lists allowed us to
separate four DGE proﬁles (Fig. 2c). (1) Mutant Response,
deﬁned as DGE outside of sibling and baseline expression range.
(2) Delay, where mutant gene expression is different from wild-
type and heterozygous siblings, but the same as in somite-
matched baseline embryos and therefore likely due to develop-
mental delay. (3) No Delay, where mutant gene expression is the
same as in siblings and therefore not affected by the morpholo-
gical delay. (4) Discard, where DGE is unreliable due to normally
high variance in the baseline or overall low expression.
The effect of this ﬁltering is to make the signal of the speciﬁc
mutant response stronger (Fig. 2d, e). For example, Fcho2 is a
gene required for the production of clathrin-coated vesicles26. In
the analysis of Gene Ontology (GO) terms for the Fcho2 mutant
line, in which homozygous embryos are delayed at E9.5, terms
such as intracellular protein transport, endosomal transport and
asymmetric protein localisation are promoted to the top of the list
when using the Mutant Response DGE list only (Fig. 2d).
Similarly, the transcriptome proﬁle in mutants of Hira, a histone
chaperone that also affects histone gene regulation27, is enriched
for genes associated with GO terms such as histone exchange,
nucleosome assembly, regulation of transcription and mRNA
splicing, after taking delay into account (Fig. 2e). We have
developed an online tool called Baseline CompaRe (https://www.
sanger.ac.uk/science/tools/dmdd/dmdd/) that enables researchers
to separate developmental delay from primary transcriptional
response in suitable RNA-seq datasets. Users can upload count
data and the app will run DESeq2, overlap the results, and
produce DGE lists for the four response categories.
The same tissues are affected by delay across mutant lines.
Given that there is a set of genes prone to appearing in DGE lists
due to mutants being developmentally delayed, we tested whether
the same genes appear in the Delay category for multiple mutants.
Generally speaking, the overlap between genes in the Delay
category from different mutant lines is small (Fig. 3a). Of the 73
mutant lines, 40 were designated as delayed and homozygous
embryos could be recovered in 32. For 6 of the 32 lines, no genes
were assigned to the Delay category. In the remaining 26 lines, the
largest pairwise overlap of the DGE lists is 30.9% (Source Data for
Fig. 3a). The largest overlaps generally appear in the most delayed
lines which tend to have the longest Delay category lists.
We then sought to investigate whether the same tissues, rather
than individual genes, are affected by delay in different mutant
lines. To this end we analysed enrichment of Edinburgh Mouse
Atlas Project Anatomy28,29 (EMAPA) ontology terms associated
with the gene lists (Fig. 3b–e). This conﬁrmed that 17 of 26
delayed lines shared tissue enrichments in the Delay category
(Fig. 3c) whereas the Mutant Response DGE lists produced
diverse enrichments (Fig. 3b). As expected only a few No Delay
and Discard lists produced enrichments, with no common theme
among mutant lines (Fig. 3d, e). Of the genes that appeared in the
No Delay lists frequently (deﬁned as being in more than six
mutant lines), those involved in cardiovascular development,
such as S1pr1 and Pecam1, and nervous system genes, for
example Gbx2 and Wnt5b, are enriched (Supplementary Fig. 3,
Supplementary Data 6). This suggests these tissues can develop
normally despite apparent global developmental delay.
Transcriptional similarities of ciliopathy mutants. Half of the
lines analysed here had at least one embryo with fewer than
20 somites (Fig. 4a, coloured bars in the 12–14 Theiler Stage
categories). Notably, this did not only occur in homozygous
embryos, reﬂecting variation in the pace of development even in
wild-type embryos. In most lines (53 of 73), the targeted gene was
at signiﬁcantly lower levels in either homozygous or heterozygous
mutants than in wild-type embryos (Fig. 4b, see Source Data for
Fig. 4b for p values). Applying the delay analysis described above
(Accounting for Developmental Delay) substantially reduced the
Mutant Response category DGE lists for the most delayed mutant
lines. Twenty-two of the delayed lines had a shortened DGE list
with a mean reduction of 47% (Fig. 4c; comparing pre- and post-
ﬁlter columns). In a few cases (e.g. Tial1) the lists are longer, most
likely due to an increase in detection power caused by inclusion of
the baseline samples. Generally, there was no, or only a very
small, transcriptional response when comparing expression
between heterozygous and wild-type embryos (Fig. 4c, het vs. wt
column). There was no correlation between severity of phenotype
and timing or level of expression of the mutated gene during the
baseline stages (Fig. 4d). We assessed the medical relevance of this
dataset and found that over a third (28/73) of the genes included
in this study have human orthologues that have previously been
implicated in human disease (Fig. 4e).
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For a comparative assessment of the mutant responses
across all lines, we performed enrichment analysis for GO terms
and EMAPA terms. In contrast to the Delay response, enriched
GO/EMAPA term sets for the Mutant Response DGE
lists differed from line to line (Figs. 3c, 5a). The most
frequently enriched GO term across all lines was “response to
hypoxia” (GO:0001666) which might reﬂect stress or placental
defects17.
Although generally the enriched terms differed between lines,
small groups of lines that shared similar sets of enriched terms
were found (Fig. 5a). One group of mutants in which similar sets
of terms were enriched contained genes previously implicated in
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ciliopathies (Fig. 5a, grey box). Impaired morphology or function
of cilia very early in development can lead to a disruption in left-
right asymmetry which is easily deﬁned by situs inversus
phenotypes. Another characteristic early ciliopathy phenotype is
polydactyly, which is caused by decreased Shh signalling in the
developing limb bud. Among the mutant lines in this study we
found ﬁve genes which have been previously linked to human
ciliopathies: B9d2, Cc2d2a, Rpgrip1l, Ift140 and Nek930. The GO/
EMAPA enrichment proﬁles of these mutant lines clustered
together with a sixth gene, the kinesin 2 complex member Kifap3,
which was not previously implicated in ciliopathies (Figs. 3b, 5a).
This prompted us to investigate the proﬁle of another complex
member, Kif3b. Both genes show ciliopathy phenotypes in mice,
namely situs inversus in Kif3b homozygous embryos31 and
polydactyly in Kifap3 homozygous embryos (IMPC16). These
early developmental phenotypes are caused by impaired cilia-
dependent Shh signalling32,33.
Examining the overlap of DGE in the seven lines showed that
the majority of genes that were differentially expressed in at least
four of the mutants (Fig. 5b) are known downstream targets of
Shh signalling34–43 or are implicated in interactions with the Shh
pathway44–49. The remaining three genes in this list are two
poorly described noncoding RNAs (Gm3764, Gm38103) which
might be potential Shh interactors and the transcription factor
Sox21 which has not been associated with Shh signalling before.
Gm3764, like Shh, is expressed in the embryonic ﬂoor plate at
E8.5 (Expression Atlas50). Gm38103 is located on chromosome 12
between Nkx2-1 and Nkx2-9, which are also downstream of Shh
signalling; however, this noncoding RNA could also constitute an
alternative 3′ end of Nkx2-9.
Assigning function to known and previously uncharacterised
genes. After establishing that our approach can identify speciﬁc
transcriptome proﬁles from whole-organism RNA-seq in known
pathways like Shh signalling in ciliopathy genes, we tested if we
could link less well-described genes to known molecular or
developmental pathways. We analysed the DGE list for the
Zkscan17 mutant line by GO term enrichment, which produced
terms that could be grouped into central nervous system, cardiac
and microtubule development or functions. The human homo-
logue ZNF496 has been shown to bind to JARID2, suggesting a
role in heart development51. The differentially expressed (DE)
genes responsible for the GO term annotations are mainly asso-
ciated with neuronal function (Fig. 5c). For example, transcripts
of three genes coding for synapse-located Slitrk proteins52, whose
human homologues are associated with schizophrenia and
Tourette syndrome53, are less abundant in Zkscan17 mutants.
This implicates Zkscan17 in neuronal function, which has not
been deﬁned before.
Another example where we can suggest a possible function for
a previously uncharacterised gene is Hmgxb3. The DE genes in
this line are associated with just 23 GO terms that are mainly
linked to DNA damage/repair and G1/S-phase transition, but also
cilium morphogenesis (Fig. 5d). Because some of the cilia genes
are also components of centrioles, our work suggests they might
be involved in the cell cycle instead of, or as well as, ciliogenesis.
Nadk2 catalyses the phosphorylation of nicotinamide adenine
dinucleotide (NAD) to NADP in mitochondria. The allele used in
this study, Nadk2tm1b(EUCOMM)Wtsi, shows complete penetrance
of pre-weaning lethality and moderate to slight morphological
delay at E9.516 (Fig. 4a), whereas Nadk2tm1a(EUCOMM)Wtsi
produces phenotypic homozygous adults54. We found 5976 DE
genes in the transcriptional mutant response of the former. One
of the most prominent signals was a marked reduction in
expression of heme biosynthesis enzymes and globins (Fig. 6a–c).
Expression of all but one of the enzymes in the heme pathway was
reduced. The mitochondrial iron importer Slc25a37 and all globin
genes also showed large decreases in expression demonstrating a
link between reduced or absent heme and a dramatic down-
regulation of globins. Although baseline globin gene expression
increases from E8 to E10.5, we were able to distinguish the
mutant response from delay—due to the magnitude of the
transcript reduction (Fig. 6c).
We detected reduced expression of a number of erythrocyte and
blood group genes, such as Slc4a1, Gypa and Kel (Fig. 6a). Taken
together, these data suggest a substantial reduction or absence of
erythrocytes in the homozygous embryos. To conﬁrm this, we
analysed HREM data of six Nadk2tm1b(EUCOMM)Wtsi homozygous
mutants and three wild-type littermates (Fig. 6d–i). Homozygous
mutants showed either global delay or delayed development of the
caudal body parts (Fig. 6e, f) and malformations of pharyngeal
arch arteries and dorsal aortae. Neither heart, arteries nor veins
contained erythrocytes. Only in some vessel segments could
scattered blood cells be detected (Fig. 6h, i). By contrast, blood was
readily detected in wild-type littermates (Fig. 6g). This demon-
strates a lack of erythrocytes in the homozygous mutant embryos,
as suggested by the transcriptome proﬁling.
Transcription analysis outside gene annotation. During the
analysis, we noticed abnormal expression and thus potential de-
repression of repeats (as deﬁned by RepeatMasker) in 12 of the 73
expression proﬁles (Supplementary Fig. 4a). In light of increasing
evidence of the importance of repeat elements and their control in
processes such as gene regulation55, germline differentiation56
and cancer57, we examined transcription outside annotated exons
(Fig. 7a). After identifying the differentially expressed repeat
instances (DERs), for example, long interspersed elements
(LINEs), we found that the Dhx35 and Morc2a mutant lines
Fig. 2 Separating the delay signal. a Principal component analysis (PCA) of all experimental samples in the study using the data for all genes. Principal
component (PC) 2 and PC3 are plotted, points are coloured by recorded number of somites. The variance explained by each component is in brackets. The
left-hand plot shows homozygous embryos (diamonds) and the right-hand heterozygous (squares) and wild-type (circles) embryos. Somite number is
correlated with PC3. b Analysis strategy. Each delayed line was analysed with DESeq2 in three different ways (see Supplementary Fig. 2) and the
differentially expressed (DE) gene lists overlapped. Four categories of genes were produced based on their position in the Venn diagram; 1. Mutant
Response, 2. Delay (mRNA abnormal), 3. No Delay (mRNA as wt) and 4. Discard. c Examples of genes from each category. Plots show expression
levels (normalised counts) of the gene in embryos (siblings= squares, homozygous= diamonds) from the Brd2 mutant line (Expt= experimental
samples) as well as baseline samples (circles) of matching somite stages. Homozygous mutants are circled. Genes shown are Mutant Response: Amt
(ENSMUSG00000032607), Delay: Nell2 (ENSMUSG00000022454), No Delay: Plppr3 (ENSMUSG00000035835) and Discard: Cdc42bpb
(ENSMUSG00000021279). d, e Effect of ﬁltering on Gene Ontology (GO) enrichment. Plots of the top 20 (by p value) enriched GO terms (Biological
Process) in both unﬁltered and Mutant Response DE gene lists. The size of the points represents fold enrichment of the term (Observed/Expected) and
they are coloured by −log10[p value] (no point means the term is not in the top 20 for that gene list). The numbers are the position of the term in each list
ranked by p value (no number means the term is not enriched for that gene list). d Enrichments for the Fcho2 (ENSMUSG00000041685) mutant line.
e Enrichments for the Hira (ENSMUSG00000022702) mutant. Source data are provided as a Source Data ﬁle
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showed large numbers of DERs in speciﬁc genomic region types
(Fig. 7b). In contrast to the other 11 lines, DERs in the Dhx35 line
were mostly intronic whereas those in Morc2a were mostly
intergenic (Fig. 7b).
Intronic DERs in Dhx35 mutants. Dhx35 encodes a putative
RNA helicase suggesting involvement in RNA structure
regulation. DERs in Dhx35 mutants were mostly intronic and
dominated by SINEs in the sense orientation (Fig. 7b, Supple-
mentary Fig. 4b). The vast majority of intronic DERs in Dhx35
mutants were not found in the other mutants (Supplementary
Fig. 4c). One hundred and thirty-nine genes (115 unique to
Dhx35) contained a signiﬁcant enrichment of 407 intronic DERs
when compared to the total number of intronic repeats (Fig. 7c;
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for p values see Source Data for Fig. 7c). Expression of all but one
of the enriched intronic DERs was increased in Dhx35 mutants
compared to wild-type embryos (Supplementary Fig. 4d). One
explanation for this could be that the genes surrounding the
DERs are differentially expressed, causing the repeats they con-
tain to appear differentially abundant as well. If this were the case,
the fold change of the gene and of the DERs it contains should be
correlated. However, the mean fold change of DERs unique to
Dhx35 does not correlate with the fold change of the surrounding
gene, whereas it does for DERs that occur in other mutant lines in
addition to Dhx35 (Fig. 7c; Pearson correlation coefﬁcient=
0.905). This suggests the differential expression in DERs unique
to Dhx35 is not caused by differential expression of the genes
harbouring the repeats.
Individual inspection of introns containing DERs suggested an
increase in intron retention in Dhx35 rather than de-repression
of speciﬁc repeats (Supplementary Fig. 5). We therefore used
iDiffIR (https://bitbucket.org/comp_bio/idifﬁr), a tool for asses-
sing intronic and exonic read depths, to check for increased
intron retention in Dhx35 (and Morc2a and Hmgxb3 as
controls). A similarly small proportion of introns showed
signiﬁcant intron retention—for Dhx35, 73 of 39,203 introns
tested were signiﬁcant (adjusted p value < 0.05 after multiple
testing correction), and for the Hmgxb3 and Morc2a controls 58
(of 37,971) and 51 (of 36,807) introns, respectively, showed
signiﬁcant retention (iDiffIR results ﬁles can be downloaded at
https://doi.org/10.6084/m9.ﬁgshare.7613528). This suggests that
intron retention is not occurring genome-wide, but rather that
Dhx35 is either acting on speciﬁc introns post-transcriptionally
or speciﬁc regions in the introns are transcribed independently of
the surrounding gene.
De-repression of intergenic L1 LINEs in Morc2a mutants.
MORC2, the human orthologue of Morc2a, has been linked to
Charcot−Marie−Tooth disease and repression of hetero-
chromatin associated with the HUSH complex58. Furthermore,
MORC2 and HUSH complex subunits can bind and silence
young LINE-1s in cell lines59. In contrast to the other 12 mutant
lines, 80% (1028 of 1293) of the DERs in Morc2a were intergenic
(Fig. 7b). Among instances within introns, we found DE LINEs—
and, at a lower frequency, DNA and LTR families—were more
often anti-sense than sense, unlike almost all other repeat groups
in all mutants, which were more likely to be sense (Supplemen-
tary Fig. 4b). This suggests the repeat expression is independent
of the gene. We performed enrichment analysis for each repeat
family (Fig. 7d) and identiﬁed 14 families enriched for DERs
(adjusted p value < 0.05, binomial test, see Source Data for
Fig. 7d). The majority of these were from the LINE and LTR
groups, all of which showed increased expression (Fig. 7d, heat-
maps). The L1MdGf_I family, a young and expanding subfamily
of L1 elements potentially capable of retrotransposition60, stands
out, with 693 DERs out of 3132 instances. The majority (86%) of
these are intergenic with only three (0.4%) found in exons, sug-
gesting a preference for transcriptionally silent regions. These
L1MdGf_I repeat instances are rarely expressed in sibling
(Fig. 7d, heatmaps) or baseline embryos (Supplementary Data 7).
The enrichments for L1MdGf_I, MMERGLN-int and MMETn-
int families were preserved after ﬁltering for repeat lengths greater
than 4 kbp, suggesting it is not an artefact of not having full-
length repeats (Fig. 7d, Supplementary Fig. 4e). Notably, one
MMERGLN-int and 57 (8.2 %) L1MdGf_I DERs map to the Y
chromosome, but are found in RNA derived from both male and
female embryos (Fig. 7d, heatmap; see Source Data for Fig. 7d2).
This raises the possibility that these repeat instances have
undergone transposition, are present as copies on autosomes, and
are thus capable of generating mRNA in female embryos. To look
at the repeat families independently of genome location we took
the total number of reads which map to each repeat family, cal-
culated the mutant versus sibling log2 fold change and plotted this
against the total number of counts (Supplementary Fig. 4f). This
conﬁrms that overall L1MdGf_I, MMERGLN-int and MMETn-
int families increase in abundance in the Morc2a mutant
embryos.
We also examined the list of 1392 DE genes associated with the
Morc2a mutant using reads mapped independently of the gene
annotation, and found a number of genes of interest. Tug1, a non-
coding anti-sense RNA ofMorc2a, and Cbx7, were both increased
in expression—these are known to be involved in polycomb-
mediated repression and cell-cycle arrest61. Other cell-cycle genes
were also upregulated, including Ccng1, Cdkn1a and Gtse1.
D1Pas1 62 and Zp3r, which despite being described as testis
speciﬁc were expressed in both male and female homozygous
embryos. Taken together, these dysregulated genes suggest that
male germline or gonad development and the cell cycle may be
affected in Morc2a mutants.
Discussion
The DMDD programme has analysed 247 embryonic or perinatal
lethal mutant lines over the last 5 years and created an important
public resource11. In this study, we have generated transcriptional
proﬁles for 73 of these lines to identify the molecular signatures
underlying embryonic lethality. We have developed a procedure
to enrich for primary responses to gene loss by separating out the
transcriptional changes due to developmental delay. This has
enabled us to assign function to previously poorly characterised
genes. The results are available to download (https://doi.org/
10.6084/m9.ﬁgshare.c.4127441) and can be visualised and inter-
rogated in our online tool Baseline CompaRe.
For 20 of the lines only heterozygous and wild-type embryos
could be retrieved at mid-gestation. We detected only very limited
gene expression changes in the heterozygotes even though the
transcripts of the targeted genes themselves were less abundant.
By contrast, adult phenotypes have been observed in hetero-
zygotes in 12 of these lines, for example, decreased bone density
Fig. 3 Anatomical term enrichment analysis. a Pairwise overlaps between Delay gene lists. The heatmap on the right shows the Jaccard similarity index
(number in both lists/number in either list) for pairs of delayed mutant lines. The heatmap has been hierarchically clustered and the tree is displayed on the
left along with the number of genes in each Delay gene list. The category of delay for each line is indicated by coloured diamonds (yellow= Slight, blue=
Moderate, purple= Severe). b–e Bubble plots of the enriched Edinburgh Mouse Atlas Project Anatomy (EMAPA) terms produced from the four categories
of differentially expressed genes. The mutant lines are displayed on the x-axis and the terms are on the y-axis. The ordering of mutants on the x-axis was
determined by hierarchical clustering of the overlap (Jaccard Index) of terms between lines. The enriched terms on the y-axis were simpliﬁed by
aggregating to terms at the top of the EMAPA ontology graph. The size of the bubbles represents the number of terms that have been simpliﬁed to the
higher-level term and they are coloured by maximum −log10[p value]. Mutant lines with no enrichments have been excluded from the plots. b Mutant
Response. Small groups of lines have similar tissues enriched. The grey box highlights the ciliopathy lines that cluster together based on similarity of
enriched EMAPA terms. c Delay. The enriched tissues are more uniform across the lines. d No Delay. e Discard. For No Delay and Discard fewer lines have
enriched terms and there is little pattern to the enriched tissues
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Fig. 4 Summary of mutant lines. a Diagram of the stages of embryos collected coloured by genotype (green=wild type, blue= heterozygous, red=
homozygous). The horizontal length of the bars represents the number of embryos at each Theiler stage for each genotype. The mutant lines are arranged
from top to bottom by decreasing amount of delay. Lines are categorised by the most delayed embryos collected (TS12= Severe, TS13=Moderate,
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in Atxn10 (IMPC16). This suggests that these defects arise at
stages later than E9.5.
Many homozygous embryos were already developmentally
delayed at E9.5. Indeed, the PCA analysis demonstrated that the
third largest source of variation (PC3) in the experimental
embryos can be attributed to developmental progression as
measured by somite number (Fig. 2a). We therefore devised a
strategy to isolate the direct transcriptional response to gene
disruption from a more general delay signal in the transcriptome
proﬁles. Comparing GO term enrichments with and without
ﬁltering showed that GO terms matching the previously estab-
lished functions of well-characterised genes like Fcho2 and Hira
(Fig. 2d, e) moved to the top of their enrichment lists after
ﬁltering, demonstrating the validity of this approach. It is
important to note that, using this system, we may miss some
genes that are directly affected by the mutation, but also change
substantially in expression level over the time period of
the baseline.
We have used somite number to stage embryos and it is pos-
sible that a mutation directly affects somite number without
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Fig. 5 Mutant response overview and examples. a Bubble plot of the enriched Gene Ontology (GO) terms shared across most mutant lines, with lines on
the x-axis and GO terms on the y-axis. The ordering of mutants on the x-axis was determined by hierarchical clustering of the overlap (Jaccard Index) of
terms between lines. The size of the bubbles represents fold enrichment (Observed Genes/Expected) and they are coloured by −log10[p value]. The group
of ciliopathy mutants are highlighted with a grey box and a bar at the bottom. b Heatmap of the log2[fold change] of genes that are differentially expressed
(DE) in at least four of the seven mutants identiﬁed as having similar ciliopathy proﬁles. Mutant lines are shown on the x-axis and DE genes on the y-axis.
Phenotypes associated with mutations in human and mouse are shown above the heatmap. The DE genes have been categorised into three groups,
Downstream of Shh signalling, Shh signalling interactors and Novel. c Heatmap of 17 DE genes from the Zkscan17 mutant line associated with central
nervous system (CNS), cardiac or microtubule GO terms. The heatmap displays expression values as mean centred and scaled normalised counts in all
samples and the GO categories associated with each gene are shown to the right of the heatmap. d Network diagram produced by Enrichment Map
(Cytoscape App) of the GO term enrichment in the Hmgxb3 mutant line. The nodes represent enriched GO terms and the edge widths are proportional to
the overlap of genes annotated to each term. Not all enriched GO terms are included. Source data are provided as a Source Data ﬁle
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causing delay in other tissues. To allow for this possibility we have
included a No Delay category in our analysis. We ﬁnd many
genes that change expression over the baseline time course are
not affected by delay, but are expressed at the same level in
morphologically delayed embryos as in wild-type and hetero-
zygous siblings. That is their expression is at the appropriate level
for an E9.5 embryo rather than matching the stage as determined
by their somite number. For example, in the Fcho2 line, this is the
case for genes involved in cardiovascular development such as
S1pr1 and Pecam1 and nervous system genes such as Gbx2 and
Wnt5b (Supplementary Fig. 3a–b). This suggests that some tissues
in certain mutants continue to develop at the same rate as in wild-
type embryos despite the apparent global developmental delay as
measured by somite number.
In our whole-organism RNA-seq analysis we detected the vast
majority (97.0%) of genes identiﬁed in single-tissue RNA-seq at a
comparable embryonic stage (Supplementary Fig. 1c), which
demonstrates the sensitivity of whole-organism RNA-seq. In
addition, DGE lists and their corresponding GO term enrichment
for lines of known mutants establish this method as a valid
screening tool. For example, human orthologues of ﬁve genes
included in this study have a conﬁrmed role in human
ciliopathies, often characterised by impaired Shh signalling and
showed overlapping DGE lists. We identiﬁed two additional lines,
Kif3b and Kifap3, that showed similar proﬁles and have mor-
phological phenotypes such as polydactyly and situs inversus.
Both proteins bind to Kif3a to form the kinesin 2 complex
facilitating the anterograde transport of cargo proteins along cilia
microtubules63. Taken together, this makes these genes strong
candidates for idiopathic ciliopathies. Our analysis also implicates
two non-coding transcripts and Sox21 in Shh-related early
developmental processes.
Finding members of the Shh pathway in all the DGE lists of
ciliopathy genes in our collection makes us conﬁdent to predict
possible functions for less well-described genes like Zkscan17
(Fig. 5c) and Hmgxb3 (Fig. 5d). Our expression proﬁles suggested
the absence of erythrocytes in Nadk2 mutants and this was
conﬁrmed by our morphological analysis. The absence of ery-
throcytes in Nadk2 mutants could be a dissection artefact due to
rupturing of large blood vessels; however, this is highly unlikely to
occur in all six homozygous mutants, but not the wild-type sib-
lings. Further work is necessary to ascertain whether the lack of
red blood cells is causal for the global developmental delay in
these mutants.
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We found changes in large numbers of repeat elements in
two of the mutant lines. Homozygous mutant Dhx35 embryos
displayed differentially abundant intronic repeat elements, the
majority of which are SINEs, in the sense orientation. The most
obvious explanation for this is that the genes containing the
introns affected are also differentially expressed and the repeats
appear affected as a consequence of sequencing unprocessed
mRNA. This is unlikely since the majority of genes containing
the DE repeat instances have much smaller expression changes
which are often in the opposite direction. Our data suggest that
speciﬁc introns are being retained at a higher rate in homo-
zygous mutants than in wild-type embryos. Future in-depth
analysis of this putative RNA helicase would be needed to
better understand the function and mechanisms of intron
retention.
In contrast to Dhx35, de-repressed repeat elements in homo-
zygous Morc2a embryos were mostly in intergenic regions. L1s
were most affected with over 20% of 3132 instances of L1MdGf_I
family repeats de-repressed. This class of repeats was almost
completely silent in wild-type embryos at E9.5. Notably, sub-
stantial numbers of DE L1MdGf_I repeats mapped to Chr Y, but
were detected in female embryos. Repeat sequences are notor-
iously difﬁcult to map and it is therefore possible this is caused by
mis-mapping of reads or accumulated polymorphisms. Alter-
natively, this suggests the possibility that if, as has been sug-
gested60, these elements are capable of retrotransposition, they
have been mobilised in the Morc2a KO background C57BL/
6NTac/USA and instances now reside on autosomes, but are not
present in the reference sequence of C57BL/6J. Ultimately only
whole-genome sequencing of the Morc2a background will be able
to resolve this. The LINE families L1MdGf and L1MdT and the
LTR family MMERGLN-int lose their hypermethylation in sperm
during the sperm to zygote transition which later gets reinstated
by E6.5/7.5 64. Because we observed expression of these families at
E9.5, our data suggest that Morc2a is involved in this develop-
mental process. Similarly, a Morc1-deﬁcient mouse has de-
repressed transposable elements in the male germline including
instances of the L1MdGf, MMERGLN and MMETn-int
families65.
To allow other researchers to view the data for the mutant lines
presented here and apply our analysis method to their own data,
we have produced a tool called Baseline CompaRe. This is
designed to take count data and sample information ﬁles and run
DESeq2 as in Supplementary Fig. 2. The results are presented as
tables split into the four categories (Mutant Response, Delay, No
Delay and Discard). Baseline CompaRe produces PCA plots
and graphs of normalised counts for individual genes. It is
available at https://www.sanger.ac.uk/science/tools/dmdd/dmdd/
or to download for use locally at https://github.com/richysix/
baseline_compare. Also, we have provided a list of the genes that
contribute most to the somite number signal as captured by PC3.
These genes change the most over the time course and are
therefore most prone to inappropriately appearing differentially
expressed because the homozygous embryos are developmentally
delayed (Supplementary Data 5).
This work creates a large transcriptomic resource, which
together with the morphological phenotype information on these
lines, will provide valuable information to researchers and further
the understanding of the role of these genes in early mammalian
development.
Methods
Animal care. The care and use of all mice in this study were in accordance with
UK Home Ofﬁce regulations, UK Animals (Scientiﬁc Procedures) Act of 1986 (PPL
80/2485 and P77453634) and were approved by the Wellcome Sanger Institute’s
Animal Welfare and Ethical Review Body.
Sample collection. All mice were produced and maintained on a C57BL/6N
genetic background. All embryos were produced by the Wellcome Sanger Institute
(https://www.sanger.ac.uk/mouseportal/) as part of the DMDD project11. Gene
knock-out lines were produced as part of a systematic programme coordinated by
the International Mouse Phenotyping Consortium16 and are available from http://
www.mousephenotype.org. Lines were designated lethal if no homozygous mutants
were present amongst a minimum of 28 pups at P14. For each line, one or more
litters from heterozygous intercrosses were harvested at embryonic day E9.5. After
culling the dam by cervical dislocation, embryos were dissected out of the uterus in
cold PBS buffer, removed from the decidua and cleared of all surrounding mem-
branes. Each embryo was genotyped using yolk sac samples, staged by counting the
number of somites and placed into RNAlater® stabilisation solution overnight at
4 °C, before storing at −20 °C. Samples are detailed in Supplementary Data 1.
Sample genotyping and sex determination. The genotype of each sample—
excluding those made by CRISPR or where the lacZ reporter gene was removed—
was checked by aligning unmapped reads to lacZ (sequence extracted from https://
www.i-dcc.org/imits/targ_rep/alleles/30096/escell-clone-cre-genbank-ﬁle) using
BWA66, counting the aligned reads and normalising using the same DESeq2 size
factors as used for creating BioLayout input. Normalised counts were used to check
which samples were wild type (lacking lacZ counts), heterozygous (intermediate
lacZ counts) and homozygous (highest lacZ counts). The genotypes of 30/1098
(2.7%) samples were changed by this analysis and noted in the metadata submitted
to the European Nucleotide Archive.
The sex of each sample was checked by assessing the normalised counts for
Xist (ENSMUSG00000086503) and four Y chromosome genes with large
expression level ranges (ENSMUSG00000069049, ENSMUSG00000068457,
ENSMUSG00000069045, ENSMUSG00000056673). Female samples were deﬁned
as those with Xist counts above 400 and levels of ENSMUSG00000069049,
ENSMUSG00000068457, ENSMUSG00000069045 and ENSMUSG00000056673
below 20, 6, 10 and 60 respectively. The sexes of 43 samples were changed by this
analysis and noted in the metadata submitted to ENA.
RNA extraction and sequencing. Individual embryos were lysed in 300 µl Trizol
with a 5 mm stainless steel bead (Qiagen) for 2 min at 20 Hz in a tissue lyser
(Qiagen). After mixing of 200 µl chloroform to the homogenate and incubation for
30 min at room temperature the upper phase was transferred to a new tube. One
volume of fresh 70% ethanol was added and the RNA was puriﬁed over a spin
column (Qiagen RNeasy MinElute). After quantiﬁcation (Qubit RNA BR) the
sample was treated with DNAse enzyme (Qiagen) and puriﬁed over a spin column
again. Up to 500 ng total RNA was used for the generation of strand-speciﬁc RNA-
seq libraries containing unique index sequences in the adapter. Libraries were
pooled and sequenced on Illumina HiSeq.
RNA-seq analysis. FASTQ ﬁles were aligned to the GRCm38 reference genome
using TopHat2 67 (v2.0.13, options: --library-type fr-ﬁrststrand). Ensembl 88 gene
models were supplied to TopHat2 to aid transcriptome mapping. Sequence quality
of each library was manually assessed one knock-out line at a time using the output
of QoRTs68. Libraries were quality controlled on insert size, GC content and proper
pairs. Counts for genes were produced using htseq-count69 (v0.6.0 options:
–stranded= reverse) with the Ensembl v88 annotation as a reference. For the
comparison to RNA-seq on dissected tissues (PRJEB4513), data were downloaded
from the Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/sra) and
processed in the same way.
Correlation networks. Normalised counts obtained from DESeq2 were used to
create a ﬁle for inputting into BioLayout Express3D 21,22. The Pearson correlation
cut-off was set to 0.8; gene pairs with a correlation coefﬁcient above this are linked
by an edge in the input graph (10,844 genes). After running MCL, clusters with
fewer than ﬁve genes were removed (36 genes) which produced 111 clusters ran-
ging in size from 6 to 2706 genes. Genes in the batch outlier cluster (Cluster006)
were then removed in subsequent analyses. The networks in Supplementary Fig. 1
were produced by using the samples as nodes and setting the correlation coefﬁcient
cut-off to the maximum value that still includes all samples (0.96 and 0.97 for
Supplementary Fig. 1a and b respectively).
Incorporation of RNA-seq data into Ensembl. RNA-seq models were also gen-
erated using our Ensembl RNA-seq pipeline70. Models were generated by assigning
the samples to six time points (E8_dpc, E8.5_dpc, E9_dpc, E9.5_dpc, E10_dpc,
E10.5_dpc). These data were aligned to the genome using BWA66, resulting in
3,470,792,067 reads aligning from 3,726,475,010 reads. The aligned reads were
processed by collapsing the transcribed regions into a set of potential exons. Par-
tially aligned reads were re-mapped using Exonerate71, which identiﬁed spliced
reads and introns. These introns together with the set of transcribed exons were
combined to produce transcript models, one set for each time point and one set
produced by merging data from all of the time points. The longest open reading
frame in each of these models was compared to UniProt protein sequences—
UniProt protein existence levels 1 (existence at protein level) and 2 (existence at
transcript level)—using BLAST72 in order to classify the models according to their
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protein-coding potential. The RNA-seq transcript models, indexed BAM ﬁles, and
the complete set of splice junctions identiﬁed by our pipeline are available in
Ensembl. The tracks can be switched on using the control panel (https://www.
ensembl.org/info/website/control_panel.html).
Novel genes assembly. Cufﬂinks73 and Cuffmerge were run on all samples and
novel transcripts were identiﬁed as those transcripts that did not overlap existing
annotation and that had multiple exons and canonical splice sites. To assess the
coding potential of the novel genes, models in the same region were clustered to
reduce redundancy. Transcripts that did not overlap current genes were scanned
for pfam domains using InterProScan74 (v5.25–64.0, https://www.ebi.ac.uk/
interpro/search/sequence-search). Some of the genes have subsequently been
annotated in later versions of Ensembl.
Principal component analysis. PCA used data on all 986 experimental samples
including all genes after removal of the blacklist genes. The data were transformed
using the variance stabilising transformation function provided by DESeq2 75 and
the PCA was calculated using the prcomp function in R. The genes contributing
most to PC3 (3872 genes that cumulatively contribute 50% of the variance captured
by PC3) are provided in Supplementary Data 5.
Differential expression. Differential expression analysis was done using
DESeq2 75 with the counts from htseq-count. Genes with an adjusted p value (Wald
test, Benjamini−Hochberg adjustment for multiple testing) below 0.05 were called
as differentially expressed. For standard analysis (i.e. no delayed embryos), the
model used was ~ sex+condition, which takes the sex of the embryos into account.
For lines with delayed embryos DESeq2 was run in three ways:
(1) Experimental samples (hom, het and wt) with model as ~ sex+ condition.
(2) Experimental samples and baseline samples of the stages present in the
experimental embryos using the same model (~ sex+ condition).
(3) Experimental samples and baseline samples of the stages present in the
experimental embryos using a model that takes stage into account (~ sex+
stage+ condition).
The differentially expressed gene lists were then overlapped. Genes were placed
into one of four categories based on which lists they appeared in (Fig. 2).
Repeats. Repeat annotation identiﬁed by RepeatMasker was downloaded (http://
www.repeatmasker.org/genomes/mm10/RepeatMasker-rm405-db20140131/
mm10.fa.out.gz) and ﬁltered to remove repeats marked as Simple_repeat or
Low_complexity. In order to reduce potential mapping bias, FASTQ ﬁles were
realigned to the GRCm38 reference genome using TopHat2 67 (v2.0.13, options:
--library-type fr-ﬁrststrand), but without a transcriptome reference. Counts for
repeats were produced using htseq-count69 (v0.6.0 options: --stranded= reverse).
Intronic retention was examined using iDiffIR (https://bitbucket.org/comp_bio/
idifﬁr) and custom scripts (https://github.com/iansealy/bio-misc/blob/master/
analyse_intronic_expression.pl). The results ﬁles can be downloaded from Figshare
(https://doi.org/10.6084/m9.ﬁgshare.7613528). The dataset contains a results ﬁle
for each of the Hmgxb3, Dhx35 and Morc2a lines.
Anatomical enrichment. EMAPA enrichment was done with Ontologizer76
(http://ontologizer.de) using the Parent−Child−Union calculation method and
Benjamini−Hochberg correction for multiple testing. The EMAPA ontology was
downloaded from ftp://ftp.hgu.mrc.ac.uk/pub/MouseAtlas/Anatomy/EMAPA.obo
and the annotations of EMAPA ids to MGI gene ids was downloaded from
MouseMine77 (www.mousemine.org/) using a custom python script (available
from the code repository—see Code Availability). These data were ﬁltered to use
only data from wild-type samples with the following strength annotations (Present,
Moderate, Strong, Weak, Very strong) and assay types (RNA in situ). MGI gene ids
were converted to Ensembl gene ids by downloading the mapping of one to
another from Ensembl BioMart (https://www.ensembl.org/biomart) and removing
duplicate mappings. To simplify the enriched terms, they were aggregated using the
EMAPA ontology graph. A set of terms close to the top of the ontology graph were
chosen as parent terms, such as hindbrain, branchial arch and skeletal system. For
each parent term, all its child terms were aggregated together to produce the
bubble plots.
GO enrichment. GO enrichment was performed using the R topGO package78.
The mapping between Ensembl gene ids and GO terms was retrieved from the
Ensembl database using a custom Perl script (get_ensembl_go_terms.pl) from the
topgo-wrapper repository (https://github.com/iansealy/topgo-wrapper).
Enrichment Map. The Cytoscape79 Enrichment Map plugin80 was used to visualise
the GO enrichment results (http://www.baderlab.org/Software/EnrichmentMap).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available within
the article and its supplementary information ﬁles or from the corresponding author
upon reasonable request. All sequencing data have been deposited in ENA under
accession codes: ERP010754 (baseline) and ERP008773 (mutant lines). Processed data
such as DGE lists and GO/EMAPA enrichments for each mutant line are available at
Figshare (https://doi.org/10.6084/m9.ﬁgshare.c.4127441). The source data underlying
Figs. 1d, 2a, c−e, 3b−d, 4a−c, 5c, 6b−d, and Supplementary Figs. 1d, 2, 3, 4a, b, 5a, b,
d−f, 6 are provided as a Source Data File.
Code availability
All the codes used to produce the plots are available at https://github.com/richysix/
dmdd_ﬁgs. The Baseline CompaRe code is available at https://github.com/richysix/
baseline_compare.
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